BioCentury
ARTICLE | Product Development

COVID-19 diagnostic tech tableau

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis.

March 28, 2020 2:02 AM UTC
Updated on Mar 30, 2020 at 4:07 PM UTC

In the ramp-up of testing for COVID-19, two well-established technologies have divided the forefront: RT-PCR and immunoassays. The former tests for active infection by detecting viral RNA, while the latter can be used to detect the virus itself or antibodies that develop in response to infection.

Meanwhile, a slate of newer platforms in development offers opportunities to speed up readouts without compromising accuracy. The uses range from point-of-care virus detection to monitoring disease progression and tracking the emergence of mutations. ...